DOCSLIB.ORG

Supplemental Material 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplemental Material 1 Supplemental Fig. 1 12 1mg/ml A1AT p<0.001 10 8 p=0.004 6 p=0.029 (fold change) 4 mRNA ofmRNA angptl4 at h 1 2 0 Control Prolastin Aralast A1AT Sigma Supplemental Figure 1. Adherent PBMCs were incubated with 1 mg/ml A1AT from different sources (Prolastin, Grifols; Aralast, Baxter; or Sigma Aldrich) for 1h and mRNA levels of angplt4 were determined by RT-PCR. Bars represent the mean ± SD of four experiments. Supplemental Fig. 2 12 8 h p=0.005 10 8 6 mRNA angplt4 mRNA change Fold 4 2 0 Control A1AT 0.5 mg/ml Supplemental Figure 2. HMVEC-L were incubated with 0.5 mg/ml A1AT (Calbiochem) for 8 h and mRNA levels of angptl4 were determined by RT-PCR. Bars represent the mean ± SEM of three experiments. Supplemental Table I. Influence of A1AT (1 mg/ml, 8 h) on expression of angiogenesis genesa in HMVEC-L Unigene Symbol Description Gname fold changeb Hs.525622 AKT1 V-akt murine thymoma viral AKT/MGC99656/PKB/PKB- 0,94 0,14 oncogene homolog 1 ALPHA/PRKBA/RAC/RAC- ALPHA Hs.369675 ANGPT1 Angiopoietin 1 AGP1/AGPT/ANG1 3,61 5,11 Hs.583870 ANGPT2 Angiopoietin 2 AGPT2/ANG2 0,98 0,01 Hs.209153 ANGPTL3 Angiopoietin-like 3 ANGPT5/FHBL2 1,10 0,59 Hs.9613 ANGPTL4 Angiopoietin-like 4 ANGPTL2/ARP4/FIAF/HFAR 5,79 1,66 P/NL2/PGAR/pp1158 Hs.1239 ANPEP Alanyl (membrane) APN/CD13/GP150/LAP1/P150 1,03 0,01 aminopeptidase /PEPN Hs.194654 BAI1 Brain-specific angiogenesis FLJ41988/GDAIF 0,89 0,26 inhibitor 1 Hs.54460 CCL11 Chemokine (C-C motif) ligand 11 MGC22554/SCYA11 1,04 0,15 Hs.303649 CCL2 Chemokine (C-C motif) ligand 2 GDCF- 1,09 0,14 2/HC11/HSMCR30/MCAF/M CP- 1/MCP1/MGC9434/SCYA2/S MC-CF Hs.76206 CDH5 Cadherin 5, type 2 (vascular 7B4/CD144/FLJ17376 0,96 0,14 endothelium) Hs.517356 COL18A1 Collagen, type XVIII, alpha 1 FLJ27325/FLJ34914/KNO/KN 0,99 0,09 O1/KS/MGC74745 Hs.570065 COL4A3 Collagen, type IV, alpha 3 - 0,62 0,51 (Goodpasture antigen) Hs.789 CXCL1 Chemokine (C-X-C motif) ligand 1 FSP/GRO1/GROa/MGSA/MG 0,93 0,09 (melanoma growth stimulating SA-a/NAP-3/SCYB1 activity, alpha) Hs.632586 CXCL10 Chemokine (C-X-C motif) ligand C7/IFI10/INP10/IP- 1,49 0,56 10 10/SCYB10/crg-2/gIP-10/mob- 1 Hs.89690 CXCL3 Chemokine (C-X-C motif) ligand 3 CINC-2b/GRO3/GROg/MIP- 0,66 0,23 2b/MIP2B/SCYB3 Hs.89714 CXCL5 Chemokine (C-X-C motif) ligand 5 ENA-78/SCYB5 1,54 0,36 Hs.164021 CXCL6 Chemokine (C-X-C motif) ligand 6 CKA-3/GCP-2/GCP2/SCYB6 0,90 0,13 (granulocyte chemotactic protein 2) Hs.77367 CXCL9 Chemokine (C-X-C motif) ligand 9 CMK/Humig/MIG/SCYB9/crg 0,45 0,33 -10 Hs.592212 TYMP Thymidine phosphorylase ECGF/ECGF1/MEDPS1/MNG 1,26 0,06 IE/MTDPS1/PDECGF/TP/hPD -ECGF Hs.154210 S1PR1 Sphingosine-1-phosphate receptor CHEDG1/D1S3362/ECGF1/E 1,02 0,25 1 DG-1/EDG1/FLJ58121/S1P1 Hs.516664 EFNA1 Ephrin-A1 B61/ECKLG/EFL1/EPLG1/LE 0,80 0,11 RK1/TNFAIP4 Hs.516656 EFNA3 Ephrin-A3 EFL2/EPLG3/Ehk1-L/LERK3 0,87 0,23 Hs.149239 EFNB2 Ephrin-B2 EPLG5/HTKL/Htk- 0,79 0,17 L/LERK5/MGC126226/MGC1 26227/MGC126228 Hs.419815 EGF Epidermal growth factor HOMG4/URG 1,01 0,36 Hs.76753 ENG Endoglin CD105/END/FLJ41744/HHT1/ 1,07 0,01 ORW/ORW1 Hs.437008 EPHB4 EPH receptor B4 HTK/MYK1/TYRO11 0,89 0,13 Hs.115263 EREG Epiregulin ER 1,50 0,10 Hs.483635 FGF1 Fibroblast growth factor 1 (acidic) AFGF/ECGF/ECGF- 0,89 0,55 beta/ECGFA/ECGFB/FGF- alpha/FGFA/GLIO703/HBGF1 Hs.284244 FGF2 Fibroblast growth factor 2 (basic) BFGF/FGFB/HBGF-2 1,01 0,17 Hs.1420 FGFR3 Fibroblast growth factor receptor 3 ACH/CD333/CEK2/HSFGFR3 1,36 0,29 EX/JTK4 Hs.11392 FIGF C-fos induced growth factor VEGF-D/VEGFD 1,37 0,29 (vascular endothelial growth factor D) Hs.654360 FLT1 Fms-related tyrosine kinase 1 FLT/VEGFR1 1,10 0,14 (vascular endothelial growth factor/vascular permeability factor receptor) Hs.388245 HAND2 Heart and neural crest derivatives DHAND2/FLJ16260/Hed/MG 3,13 3,75 expressed 2 C125303/MGC125304/Thing2/ bHLHa26/dHand Hs.396530 HGF Hepatocyte growth factor DFNB39/F- 1,12 0,38 (hepapoietin A; scatter factor) TCF/HGFB/HPTA/SF Hs.597216 HIF1A Hypoxia inducible factor 1, alpha HIF-1alpha/HIF1/HIF1- 1,12 0,07 subunit (basic helix-loop-helix ALPHA/MOP1/PASD8/bHLH transcription factor) e78 Hs.44227 HPSE Heparanase HPA/HPA1/HPR1/HPSE1/HS 1,04 0,12 E1 Hs.504609 ID1 Inhibitor of DNA binding 1, ID/bHLHb24 0,71 0,18 dominant negative helix-loop-helix protein Hs.76884 ID3 Inhibitor of DNA binding 3, HEIR-1/bHLHb25 0,76 0,16 dominant negative helix-loop-helix protein Hs.37026 IFNA1 Interferon, alpha 1 IFL/IFN/IFN-ALPHA/IFN- 1,42 1,14 alphaD/IFNA13/IFNA@/MGC 138207/MGC138505/MGC138 507 Hs.93177 IFNB1 Interferon, beta 1, fibroblast IFB/IFF/IFNB/MGC96956 2,70 1,76 Hs.856 IFNG Interferon, gamma IFG/IFI 1,05 0,14 Hs.160562 IGF1 Insulin-like growth factor 1 IGF-I/IGF1A/IGFI 1,22 0,15 (somatomedin C) Hs.126256 IL1B Interleukin 1, beta IL-1/IL1-BETA/IL1F2 1,52 0,41 Hs.654458 IL6 Interleukin 6 (interferon, beta 2) BSF2/HGF/HSF/IFNB2/IL-6 0,89 0,20 Hs.624 IL8 Interleukin 8 CXCL8/GCP- 1,10 0,21 1/GCP1/LECT/LUCT/LYNAP /MDNCF/MONAP/NAF/NAP- 1/NAP1 Hs.436873 ITGAV Integrin, alpha V (vitronectin CD51/DKFZp686A08142/MS 1,14 0,14 receptor, alpha polypeptide, K8/VNRA antigen CD51) Hs.218040 ITGB3 Integrin, beta 3 (platelet CD61/GP3A/GPIIIa 1,07 0,09 glycoprotein IIIa, antigen CD61) Hs.728907 JAG1 Jagged 1 AGS/AHD/AWS/CD339/HJ1/J 1,36 0,30 AGL1/MGC104644 Hs.479756 KDR Kinase insert domain receptor (a CD309/FLK1/VEGFR/VEGFR 0,96 0,12 type III receptor tyrosine kinase) 2 Hs.473256 LAMA5 Laminin, alpha 5 KIAA1907 1,11 0,19 Hs.421391 LECT1 Leukocyte cell derived chemotaxin BRICD3/CHM- 1,92 2,26 1 I/CHM1/MYETS1 Hs.194236 LEP Leptin FLJ94114/OB/OBS 1,05 0,14 Hs.82045 MDK Midkine (neurite growth- FLJ27379/MK/NEGF2 0,92 0,19 promoting factor 2) Hs.513617 MMP2 Matrix metallopeptidase 2 CLG4/CLG4A/MMP- 0,95 0,08 (gelatinase A, 72kDa gelatinase, II/MONA/TBE-1 72kDa type IV collagenase) Hs.297413 MMP9 Matrix metallopeptidase 9 CLG4B/GELB/MANDP2/MM 1,03 0,52 (gelatinase B, 92kDa gelatinase, P-9 92kDa type IV collagenase) Hs.436100 NOTCH4 Notch 4 FLJ16302/INT3/MGC74442/N 0,96 0,08 OTCH3 Hs.131704 NRP1 Neuropilin 1 BDCA4/CD304/DKFZp686A0 0,98 0,16 3134/DKFZp781F1414/NP1/N RP/VEGF165R Hs.471200 NRP2 Neuropilin 2 MGC126574/NP2/NPN2/PRO 1,08 0,18 2714/VEGF165R2 Hs.535898 PDGFA Platelet-derived growth factor PDGF-A/PDGF1 1,11 0,06 alpha polypeptide Hs.514412 PECAM1 Platelet/endothelial cell adhesion CD31/FLJ34100/FLJ58394/PE 1,10 0,29 molecule CAM-1 Hs.81564 PF4 Platelet factor 4 CXCL4/MGC138298/SCYB4 0,72 0,30 Hs.252820 PGF Placental growth factor D12S1900/PGFL/PLGF/PlGF- 1,06 0,21 2/SHGC-10760 Hs.77274 PLAU Plasminogen activator, urokinase ATF/UPA/URK/u-PA 1,12 0,13 Hs.143436 PLG Plasminogen DKFZp779M0222 0,76 0,35 Hs.125036 PLXDC1 Plexin domain containing 1 DKFZp686F0937/FLJ36270/F 0,49 0,13 LJ45632/TEM3/TEM7 Hs.528665 PROK2 Prokineticin 2 BV8/KAL4/MIT1/PK2 1,03 0,24 Hs.201978 PTGS1 Prostaglandin-endoperoxide COX1/COX3/PCOX1/PGG/H 0,73 0,12 synthase 1 (prostaglandin G/H S/PGHS- synthase and cyclooxygenase) 1/PGHS1/PHS1/PTGHS Hs.532768 SERPINF1 Serpin peptidase inhibitor, clade F EPC-1/PEDF 1,08 0,12 (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 Hs.68061 SPHK1 Sphingosine kinase 1 SPHK 0,98 0,16 Hs.301989 STAB1 Stabilin 1 CLEVER-1/FEEL-1/FELE- 1,03 0,08 1/FEX1/KIAA0246/STAB-1 Hs.89640 TEK TEK tyrosine kinase, endothelial CD202B/TIE- 0,91 0,04 2/TIE2/VMCM/VMCM1 Hs.170009 TGFA Transforming growth factor, alpha TFGA 0,82 0,29 Hs.645227 TGFB1 Transforming growth factor, beta 1 CED/DPD1/LAP/TGFB/TGFb 0,96 0,02 eta Hs.133379 TGFB2 Transforming growth factor, beta 2 MGC116892/TGF-beta2 0,90 0,14 Hs.494622 TGFBR1 Transforming growth factor, beta AAT5/ACVRLK4/ALK- 1,28 0,03 receptor 1 5/ALK5/LDS1A/LDS2A/SKR 4/TGFR-1 Hs.164226 THBS1 Thrombospondin 1 THBS/THBS-1/TSP/TSP- 1,09 0,15 1/TSP1 Hs.371147 THBS2 Thrombospondin 2 TSP2 0,98 0,06 Hs.522632 TIMP1 TIMP metallopeptidase inhibitor 1 CLGI/EPA/EPO/FLJ90373/HC 1,01 0,14 I/TIMP Hs.633514 TIMP2 TIMP metallopeptidase inhibitor 2 CSC-21K 0,88 0,05 Hs.644633 TIMP3 TIMP metallopeptidase inhibitor 3 HSMRK222/K222/K222TA2/S 2,79 2,95 FD Hs.241570 TNF Tumor necrosis factor DIF/TNF- 1,06 0,10 alpha/TNFA/TNFSF2 Hs.525607 TNFAIP2 Tumor necrosis factor, alpha- B94/EXOC3L3 1,19 0,12 induced protein 2 Hs.73793 VEGFA Vascular endothelial growth factor MGC70609/MVCD1/VEGF/V 1,02 0,34 A PF Hs.435215 VEGFC Vascular endothelial growth factor Flt4-L/VRP 1,10 0,17 C Hs.534255 B2M Beta-2-microglobulin - 0,99 0,08 Hs.412707 HPRT1 Hypoxanthine HGPRT/HPRT 1,04 0,14 phosphoribosyltransferase 1 Hs.728776 RPL13A Ribosomal protein L13a L13A/TSTA1 0,96 0,03 Hs.592355 GAPDH Glyceraldehyde-3-phosphate G3PD/GAPD/MGC88685 0,93 0,05 dehydrogenase Hs.520640 ACTB Actin, beta PS1TP5BP1 1,10 0,12 aGene expression was analyzed using angiogenesis PCR arrays.
Load more

Recommended publications
  • Epha Receptors and Ephrin-A Ligands Are Upregulated by Monocytic
    Mukai et al. BMC Cell Biology (2017) 18:28 DOI 10.1186/s12860-017-0144-x RESEARCHARTICLE Open Access EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/ maturation and promote cell adhesion and protrusion formation in HL60 monocytes Midori Mukai, Norihiko Suruga, Noritaka Saeki and Kazushige Ogawa* Abstract Background: Eph signaling is known to induce contrasting cell behaviors such as promoting and inhibiting cell adhesion/ spreading by altering F-actin organization and influencing integrin activities. We have previously demonstrated that EphA2 stimulation by ephrin-A1 promotes cell adhesion through interaction with integrins and integrin ligands in two monocyte/ macrophage cell lines. Although mature mononuclear leukocytes express several members of the EphA/ephrin-A subclass, their expression has not been examined in monocytes undergoing during differentiation and maturation. Results: Using RT-PCR, we have shown that EphA2, ephrin-A1, and ephrin-A2 expression was upregulated in murine bone marrow mononuclear cells during monocyte maturation. Moreover, EphA2 and EphA4 expression was induced, and ephrin-A4 expression was upregulated, in a human promyelocytic leukemia cell line, HL60, along with monocyte differentiation toward the classical CD14++CD16− monocyte subset. Using RT-PCR and flow cytometry, we have also shown that expression levels of αL, αM, αX, and β2 integrin subunits were upregulated in HL60 cells along with monocyte differentiation while those of α4, α5, α6, and β1 subunits were unchanged. Using a cell attachment stripe assay, we have shown that stimulation by EphA as well as ephrin-A, likely promoted adhesion to an integrin ligand- coated surface in HL60 monocytes. Moreover, EphA and ephrin-A stimulation likely promoted the formation of protrusions in HL60 monocytes.
    [Show full text]
  • Ephrin-A Binding and Epha Receptor Expression Delineate the Matrix Compartment of the Striatum
    The Journal of Neuroscience, June 15, 1999, 19(12):4962–4971 Ephrin-A Binding and EphA Receptor Expression Delineate the Matrix Compartment of the Striatum L. Scott Janis, Robert M. Cassidy, and Lawrence F. Kromer Department of Cell Biology and Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, Washington, DC 20007 The striatum integrates limbic and neocortical inputs to regulate matrix neurons. In situ hybridization for EphA RTKs reveals that sensorimotor and psychomotor behaviors. This function is de- the two different ligand binding patterns strictly match pendent on the segregation of striatal projection neurons into the mRNA expression patterns of EphA4 and EphA7. anatomical and functional components, such as the striosome Ligand–receptor binding assays indicate that ephrin-A1 and and matrix compartments. In the present study the association ephrin-A4 selectively bind EphA4 but not EphA7 in the lysates of ephrin-A cell surface ligands and EphA receptor tyrosine of striatal tissue. Conversely, ephrin-A2, ephrin-A3, and kinases (RTKs) with the organization of these compartments ephrin-A5 bind EphA7 but not EphA4. These observations im- was determined in postnatal rats. Ephrin-A1 and ephrin-A4 plicate selective interactions between ephrin-A molecules and selectively bind to EphA receptors on neurons restricted to the EphA RTKs as potential mechanisms for regulating the com- matrix compartment. Binding is absent from the striosomes, partmental organization of the striatum. which were identified by m-opioid
    [Show full text]
  • Molecular Regulation of Visual System Development: More Than Meets the Eye
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Molecular regulation of visual system development: more than meets the eye Takayuki Harada,1,2 Chikako Harada,1,2 and Luis F. Parada1,3 1Department of Developmental Biology and Kent Waldrep Foundation Center for Basic Neuroscience Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA; 2Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan Vertebrate eye development has been an excellent model toderm, intercalating mesoderm, surface ectoderm, and system to investigate basic concepts of developmental neural crest (Fig. 1). The neuroectoderm differentiates biology ranging from mechanisms of tissue induction to into the retina, iris, and optic nerve; the surface ecto- the complex patterning and bidimensional orientation of derm gives rise to lens and corneal epithelium; the me- the highly specialized retina. Recent advances have shed soderm differentiates into the extraocular muscles and light on the interplay between numerous transcriptional the fibrous and vascular coats of the eye; and neural crest networks and growth factors that are involved in the cells become the corneal stroma sclera and corneal en- specific stages of retinogenesis, optic nerve formation, dothelium. The vertebrate eye originates from bilateral and topographic mapping. In this review, we summarize telencephalic optic grooves. In humans, optic vesicles this recent progress on the molecular mechanisms un- emerge at the end of the fourth week of development and derlying the development of the eye, visual system, and soon thereafter contact the surface ectoderm to induce embryonic tumors that arise in the optic system.
    [Show full text]
  • ALL1 Fusion Proteins Induce Deregulation of Epha7 and ERK Phosphorylation in Human Acute Leukemias
    ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias Hiroshi Nakanishi*, Tatsuya Nakamura*, Eli Canaani†, and Carlo M. Croce*‡ *Department of Molecular Virology, Immunology, and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210; and †Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel Edited by Janet D. Rowley, University of Chicago Medical Center, Chicago, IL, and approved July 25, 2007 (received for review April 6, 2007) Erythropoietin-producing hepatoma-amplified sequence (Eph) re- studies revealed deregulation of some of the Eph/ephrin genes in ceptor tyrosine kinases and their cell-surface-bound ligands, the human malignancies, including up-regulation of ephrin-A1 or -B2 ephrins, function as a unique signaling system triggered by cell- in melanoma (2, 3), up-regulation of EphB2 in stomach cancer to-cell interaction and have been shown to mediate neurodevel- (4) and in breast cancer (5), and up-regulation of EphA2 in opmental processes. In addition, recent studies showed deregula- prostate (6), breast (7), and esophageal cancers (8), some of tion of some of Eph/ephrin genes in human malignancies, which were shown to be associated with tumor invasion or tumor suggesting the involvement of this signaling pathway in tumori- metastasis and therefore associated with poor prognosis. Con- genesis. The ALL1 (also termed MLL) gene on human chromosome versely, mutational inactivation of EphB2 was detected in pros- 11q23 was isolated by virtue of its involvement in recurrent tate (9) and colon cancers (10), suggesting tumor suppressor chromosome translocations associated with acute leukemias with function of this Eph receptor in the relevant tumors.
    [Show full text]
  • Epha3 Function Is Regulated by Multiple
    EPHA3 FUNCTION IS REGULA TED BY MULTIPLE PHOSPHOTYROSINE RESIDUES 2 1 Guanfang Shi\ Gang Yue , Mike Sheng\ Suzie Chen\ and Renping Zhou IDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854; 2Department of Oral Biology, New Jersey Dental School, University of Medicine & Dentistry of New Jersey, Newark, NJ 07101. Address correspondence to: Renping Zhou, Ph. D. Phone: (732) 445-3400 ext. 264; Fax: (732) 445-0687; E-mail: rzhou @rci.rutgers.edu EphA3, a member of the Eph family of tyrosine carcinoma was significantly correlated with kinase receptors, has been implicated in a regional lymph node metastasis (5). variety of tumors including melanoma, Overexpression of ephrin-B2, a ligand for EphB glioblastoma, pancreatic carcinoma, lung and receptors, in B 16 melanoma cells enhanced colon cancers. The loss of EphA3 function has integrin-mediated ECM-attachment and migration been associated with colorectal cancer. To (6). EphB2 positively regulates glioma cell identify potential roles in tumor formation, we adhesion, growth, and invasion via R-Ras signaling examined effects of EphA3 expression and (7). In contrast to promote tumor metastasis and activation on melanoma cell migration, and cancer cell line migration, Eph receptors may also identified key signal transducer docking sites of regulate the cell motility negatively. Hafner and the receptor. This analysis showed that the coworkers compared EphB6 mRNA level in human melanoma cell line WMl15 lacks benign nevi, primary melanomas, and metastatic EphA3 expression, while two other melanoma melanomas, and found a progressive and cell lines, WM239A and C8161, both retain significant reduction of EphB6 mRNA expression expression of the receptor.
    [Show full text]
  • Ephrin A4-Ephrin Receptor A10 Signaling Promotes Cell Migration
    www.nature.com/scientificreports OPEN Ephrin A4‑ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells Yu‑Lin Chen1, Yi‑Chen Yen1, Chuan‑Wei Jang1, Ssu‑Han Wang1, Hsin‑Ting Huang1, Chung‑Hsing Chen2,3, Jenn‑Ren Hsiao4, Jang‑Yang Chang1 & Ya‑Wen Chen1,5* Ephrin type‑A receptor 10 (EPHA10) has been implicated as a potential target for breast and prostate cancer therapy. However, its involvement in oral squamous cell carcinoma (OSCC) remains unclear. We demonstrated that EPHA10 supports in vivo tumor growth and lymphatic metastasis of OSCC cells. OSCC cell migration, epithelial mesenchymal transition (EMT), and sphere formation were found to be regulated by EPHA10, and EPHA10 was found to drive expression of some EMT‑ and stemness‑ associated transcription factors. Among EPHA10 ligands, exogenous ephrin A4 (EFNA4) induced the most OSCC cell migration and sphere formation, as well as up‑regulation of SNAIL, NANOG, and OCT4. These efects were abolished by extracellular signal‑regulated kinase (ERK) inhibition and NANOG knockdown. Also, EPHA10 was required for EFNA4‑induced cell migration, sphere formation, and expression of NANOG and OCT4 mRNA. Our microarray dataset revealed that EFNA4 mRNA expression was associated with expression of NANOG and OCT4 mRNA, and OSCC patients showing high co‑expression of EFNA4 with NANOG or OCT4 mRNA demonstrated poor recurrence‑free survival rates. Targeting forward signaling of the EFNA4‑EPHA10 axis may be a promising therapeutic approach for oral malignancies, and the combination of EFNA4 mRNA and downstream gene expression may be a useful prognostic biomarker for OSCC.
    [Show full text]
  • Multiplexed Targeting of Mirna-210 in Stem Cell-Derived Extracellular
    Song et al. Experimental & Molecular Medicine (2021) 53:695–708 https://doi.org/10.1038/s12276-021-00584-0 Experimental & Molecular Medicine ARTICLE Open Access Multiplexed targeting of miRNA-210 in stem cell- derived extracellular vesicles promotes selective regeneration in ischemic hearts Byeong-Wook Song 1, Chang Youn Lee2,RanKim3,WonJungKim3, Hee Won Lee3,MinYoungLee4,JongminKim5, Jee-Yeong Jeong 6 and Woochul Chang3 Abstract Extracellular vesicles (EVs) are cell derivatives containing diverse cellular molecules, have various physiological properties and are also present in stem cells used for regenerative therapy. We selected a “multiplexed target” that demonstrates multiple effects on various cardiovascular cells, while functioning as a cargo of EVs. We screened various microRNAs (miRs) and identified miR-210 as a candidate target for survival and angiogenic function. We confirmed the cellular and biological functions of EV-210 (EVs derived from ASCmiR-210) secreted from adipose-derived stem cells (ASCs) transfected with miR-210 (ASCmiR-210). Under hypoxic conditions, we observed that ASCmiR-210 inhibits apoptosis by modulating protein tyrosine phosphatase 1B (PTP1B) and death-associated protein kinase 1 (DAPK1). In hypoxic endothelial cells, EV-210 exerted its angiogenic capacity by inhibiting Ephrin A (EFNA3). Furthermore, EV-210 enhanced cell survival under the control of PTP1B and induced antiapoptotic effects in hypoxic H9c2 cells. In cardiac fibroblasts, the fibrotic ratio was reduced after exposure to EV-210, but EVs derived from ASCmiR-210 did not communicate with fibroblasts. Finally, we observed the functional restoration of the ischemia/reperfusion-injured heart by maintaining miR-210 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; the intercommunication of EVs and cardiovascular cells derived from ASC .
    [Show full text]
  • Pro‑Angiogenic Microrna‑296 Upregulates Vascular Endothelial Growth Factor and Downregulates Notch1 Following Cerebral Ischemic Injury
    MOLECULAR MEDICINE REPORTS 12: 8141-8147, 2015 Pro‑angiogenic microRNA‑296 upregulates vascular endothelial growth factor and downregulates Notch1 following cerebral ischemic injury JIE FENG1, TIANXIANG HUANG2, QING HUANG1, HUA CHEN1, YU LI1, WEI HE1, GUI-BIN WANG1, LE ZHANG1, JIAN XIA1, NING ZHANG1 and YUNHAI LIU1 1Institute of Neurology; 2Institute of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China Received June 8, 2014; Accepted June 3, 2015 DOI: 10.3892/mmr.2015.4436 Abstract. The present study examined the association between regional cerebral blood supply is critical for improving stroke microRNA (miR)-296 and angiogenesis following cerebral outcomes and post-stroke functional recovery (2). Therefore, ischemic injury, and the underlying mechanisms. A cerebral angiogenesis has become a focus in the field of ischemic stroke ischemic model was established in rats via right middle cere- investigation. bral artery occlusion. The animals were randomly divided into MicroRNAs (miRNAs), which are 21~23 nucleotide four groups (baseline, 1 day, 3 day and 7 day). Quantitative non‑protein‑coding RNA molecules, have been identified as polymerase chain reaction and western blot analyses were negative regulators of gene expression in a post-transcriptional performed to examine the expression levels of miR-296 and manner (3). Several previous studies have demonstrated that hepatocyte growth factor-regulated tyrosine kinase substrate miRNAs are essential determinants of vascular endothelial (HGS), respectively. Angiogenesis was assessed by examining cell biology and angiogenesis, and contribute to stroke patho- microvessel density. The results demonstrated that miR-296 genesis (4-7). A previous study demonstrated that glioma cells and angiogenesis were significantly upregulated, while HGS and angiogenic growth factors elevate the level of miRNA was significantly downregulated following ischemic injury.
    [Show full text]
  • BEACH-DISSERTATION-2016.Pdf
    Towards mammalian retinal regeneration: cell signaling in re-differentiating mouse Müller glia and transcriptional regulation of the axonal guidance receptor EphA5 By Krista Marie Beach B.S, O.D. DISSERTATION In partial satisfaction of the requirements for the degree of PhD in PHYSIOLOGICAL OPTICS Presented to the Graduate Faculty of the College of Optometry University of Houston May, 2016 Approved: Dr. Deborah C. Otteson, PhD (Chair) Dr. Laura J. Frishman, PhD Dr. Donald A. Fox, PhD Dr. Steven W. Wang, PhD Committee in Charge DEDICATION I dedicate this dissertation to my parents, Col. Thomas N. Beach, M.D., and Jean M. Beach, B.A., and to my two sisters, Paula J. Beach, M.S., B.S. and Laura E. Beach, B.A., B.A. for their unconditional love and support during these years of incessant study and work. ii ACKNOWLEDGMENTS I wish to acknowledge my committee members for their guidance and support: Deborah C. Otteson, PhD – chair Laura J. Frishman, PhD Donald A. Fox, PhD Steven W. Wang, PhD I wish to acknowledge the past and present members of the Otteson lab, for their personal support, friendship, and occasional help with experiments: Amanda Gall, M.S Tia Petkova, O.D., PhD Tanya Geranpayeh, B.S Laila Pillai, B.S Mary Guirguis, B.S M. Joseph Phillips, PhD Steven Huynh, B.S Jian Bo Wang, PhD Micah Mesko, B.S Kuichen Zhu, PhD I wish to acknowledge also the following people: Librarians Suzanne Ferimer and Pamela Forbes of the Weston Petty UH Library for acquiring a great many hard-to-find articles and resources.
    [Show full text]
  • Electrical Stimulation Induces Retinal Müller Cell Proliferation and Their Progenitor Cell Potential
    cells Article Electrical Stimulation Induces Retinal Müller Cell Proliferation and Their Progenitor Cell Potential Sam Enayati 1,2,3,4, Karen Chang 1, Hamida Achour 1,4, Kin-Sang Cho 1 , Fuyi Xu 5, Shuai Guo 1, Katarina Z. Enayati 1, Jia Xie 1, Eric Zhao 1, Tytteli Turunen 1, Amer Sehic 6, Lu Lu 5, Tor Paaske Utheim 1,2,3,6,7 and Dong Feng Chen 1,* 1 Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA; [email protected] (S.E.); [email protected] (K.C.); [email protected] (H.A.); [email protected] (K.-S.C.); [email protected] (S.G.); [email protected] (K.Z.E.); [email protected] (J.X.); [email protected] (E.Z.); [email protected] (T.T.); [email protected] (T.P.U.) 2 Department of Medical Biochemistry, Oslo University Hospital, 0372 Oslo, Norway 3 Department of Ophthalmology, Drammen Hospital, Vestre Viken Hospital Trust, 3004 Drammen, Norway 4 Institute of clinical medicine, University of Oslo, 0318 Oslo, Norway 5 Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA; [email protected] (F.X.); [email protected] (L.L.) 6 Department of Oral Biology; Faculty of Dentistry, University of Oslo, 0372 Oslo, Norway; [email protected] 7 Department of Plastic and Reconstructive Surgery, Oslo University Hospital, 0027 Oslo, Norway * Correspondence: [email protected]; Tel.: +617-912-7490 Received: 1 February 2020; Accepted: 17 March 2020; Published: 23 March 2020 Abstract: Non-invasive electrical stimulation (ES) is increasingly applied to improve vision in untreatable eye conditions, such as retinitis pigmentosa and age-related macular degeneration.
    [Show full text]
  • Epha5-Ephrina5 Interactions Within the Ventromedial
    ORIGINAL ARTICLE EphA5-EphrinA5 Interactions Within the Ventromedial Hypothalamus Influence Counterregulatory Hormone Release and Local Glutamine/Glutamate Balance During Hypoglycemia Barbara Szepietowska,1 Wanling Zhu,1 Jan Czyzyk,2 Tore Eid,3 and Robert S. Sherwin1 Activation of b-cell EphA5 receptors by its ligand ephrinA5 from typical warning symptoms. These protective responses are adjacent b-cells has been reported to decrease insulin secretion often disrupted in type 1 diabetic patients receiving intensive during hypoglycemia. Given the similarities between islet and insulin therapy who have a history of hypoglycemia (7). As ventromedial hypothalamus (VMH) glucose sensing, we tested a result, the fear of hypoglycemia is the major factor limiting the hypothesis that the EphA5/ephrinA5 system might function the benefits of intensive insulin treatment (8). within the VMH during hypoglycemia to stimulate counterregula- Activation of counterregulation requires effective de- tory hormone release as well. Counterregulatory responses and tection of falling glucose levels. Although a complex net- glutamine/glutamate concentrations in the VMH were assessed work of glucose sensors has been described in the central during a hyperinsulinemic-hypoglycemic glucose clamp study in – chronically catheterized awake male Sprague-Dawley rats that nervous system (9 11) and peripherally (12), the brain received an acute VMH microinjection of ephrinA5-Fc, chronic appears to have the dominant role during hypoglycemia VMH knockdown, or overexpression of ephrinA5 using an and, specifically, the ventromedial region of the hypothala- adenoassociated viral construct. Local stimulation of VMH EphA5 mus or VMH (13,14). Interestingly, VMH neurons contain receptors by ephrinA5-Fc or ephrinA5 overexpression increased, much of the same glucose-sensing machinery (e.g., gluco- whereas knockdown of VMH ephrinA5 reduced counterregula- kinase [15], ATP-sensitive K+ channels [16–18]) as pancre- tory responses during hypoglycemia.
    [Show full text]
  • Isolation and Functional Analysis of Xenopus Ephrin-A3
    Isolation and Functional Analysis of Xenopus Ephrin-A3 Taslima Khan A Thesis for the Degree of Doctor of Philosophy 1999 Division of Developmental Biology and Division of Developmental Neurobiology, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 lAA. University College, London, Gower Street, London, WCIE 6BT. ProQuest Number: 10014866 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10014866 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ''We shall not cease from exploration And the end of all our exploring Will be to arrive where we started And know the place for the first time. Through the unknown, remembered gate When the last o f the earth left to discover Is that which was the beginning; ” Little Gidding, T. S. Eliot. To My Family For Encouraging Me, Entertaining Me and For Trying, So Often, To Understand This PhD ABSTRACT ABSTRACT Segmentation is a primary requirement for the establishment of the vertebrate body plan and it is therefore of great interest to identify proteins involved in these patterning events.
    [Show full text]